Biomarkers & Precision Medicine US 2025
.png)
Westin St. Francis San Francisco, San Francisco, CA
.png?width=415&height=120&name=Biomarkers%20%26%20Precision%20Medicine%20US%202025%20(White).png "Biomarkers & Precision Medicine US 2025 (White)")
Where Big Attendance Meets Intimate Connections
Highlights of the Two-Day Event
27 - 28 October 2025 | San Francisco, CA
Experience Biomarkers & Precision Medicine US 2025
Immerse yourself in two days of unrivalled insight into the innovations shaping the future of personalised healthcare, in the heart of San Francisco. Join a vibrant community of global experts and pioneers driving precision medicine forward at the intersection of science, technology, and strategic collaboration. Featuring three innovative programmes with thirteen content tracks, the event will take a deep dive into Biomarkers & Clinical Development, Spatial Biology for Precision Medicine, and Digital Pathology & AI. Plus, enjoy an exclusive behind-the-scenes tour of UCSF’s state-of-the-art Clinical Digital Lab, including a live workflow demonstration and Q&A sessions with technical and clinical experts. Secure your place today and be part of the global movement transforming patient care through innovation and precision.
World-Class Track Keynote Speakers
Hear from a selection of world-class experts from industry and academia, across each of our thirteen conference tracks. Each track features an internationally renowned keynote speaker who will open the session with leaders at the forefront of biomarker research, spatial biology, and digital pathology & AI, offering you a unique opportunity to learn directly from those shaping the future of personalised healthcare. This year’s line-up includes Regeneron’s Brian Baker, Executive Director of Regulatory Affairs & In Vitro Diagnostics; GSK’s Lena Barbash, VP of Clinical Biomarkers and Correlative Sciences; and Elsa Flores, Associate Centre Director of the Moffitt Cancer Centre.
Leroy Hood, Co-Founder of the Institute of Systems Biology
Join Leroy Hood, Co-Founder of the Institute of Systems Biology and a pioneer in biotechnology, systems biology, and precision medicine, for a visionary keynote on the intersection of data-driven healthcare and peptide drug discovery. He will explore how integrated phenome and genome analysis can enable personalised wellness, healthy ageing, and disease prevention. Dr. Hood will also highlight breakthroughs in peptide therapeutics, where large-scale DNA synthesis and high-throughput screening are accelerating innovation. Explore how these two approaches can work together to reshape the future of precision medicine.
Ida Sim, Professor of Medicine at UCSF and Co-Director of the UCSF-UC Berkeley Joint Program in Computational Precision Health
Join Ida Sim, Professor of Medicine at UCSF and Co-Director of the UCSF-UC Berkeley Joint Program in Computational Precision Health, for a forward-looking keynote on the role of computational tools in transforming precision medicine. She will explore how AI, data integration, and digital infrastructure are enabling scalable, personalised healthcare across clinical and research settings. Drawing on real-world examples, Dr. Sim will also address the future of the field, including predictive modelling, real-time analytics, and the ethical, regulatory, and equity challenges of data-driven care.
Gain a powerful, firsthand perspective on one of the most innovative clinical trials in oncology. In this session, a patient and research advocate will share their unique insights into the I-SPY Breast Cancer Clinical Trial: an adaptive, collaborative platform trial designed to accelerate the development of more effective, personalised treatments for high-risk breast cancer. Learn how patient voices are helping to shape trial design, improve participant experience, and drive meaningful progress in precision oncology. This session highlights the vital role of advocacy in bridging the gap between research and real-world impact.
This discussion will bring together industry leaders and academics as they deliberate on the future of spatial biology and the opportunities unlocked by multi-omics. Expect in-depth dialogue on the challenges involved in moving towards the practical implementation of spatial findings and how these can translate into precision medicine. Experts will also tackle the critical challenge of integrating diverse data types, overcoming analytical and technological bottlenecks, and ensuring that spatial multi-omics insights can be applied reliably, at scale, and in real-world clinical settings.
Unwind with fellow attendees at our evening drinks reception to round off Day 1. This relaxed networking event is the ideal opportunity to reconnect with colleagues, engage with new contacts, and reflect on the day's insights.
This panel will explore the latest advances in the discovery, validation, and application of proteomic biomarkers, focusing on their role in transforming precision medicine. From improving diagnostics and prognostics to enabling targeted patient stratification, experts will share real-world insights into how proteomics is driving more personalised healthcare solutions. Join a distinguished panel of specialists from industry and academia as they deliberate on this critical area of innovation.
Join us for an exclusive behind-the-scenes tour of UCSF’s innovative Digital Pathology facilities on October 29th. This 40-minute experience includes a guided department walk-through, live digital workflow demonstration, a technical Q&A with IT experts as well as a user experience Q&A with UCSF pathologists. Two tour slots are available at 9:00 am and 10:30 am – reserve your place when registering for the event now! Only limited spaces are available.
.jpg?width=2819&height=1174&name=74dfee8e-75c7-46e0-9f51-31b709af2ede-2-5668375logo-Nanion_logo_black_RGB_300dpi-(2).jpg){kind=logo}
Connect and Network
Experience an event that celebrates meaningful, one-on-one connections in a dynamic, bustling atmosphere. With Biomarkers & Precision Medicine US 2025, enjoy a vibrant crowd with the warmth of personal interactions and curated experiences